At the news
? BEARISHIMPACT 7/10 EFFECT filed Nov 13, 2026 at 00:15 ET
The SEC declared effective Traws Pharma's S-1 registration (File No. 333-299644) on November 12, 2026, covering up to 135,135,135 shares for resale by Roth Principal Investments under a committed equity facility. This allows the company to sell up to $50 million of newly issued shares at a 6% discount to VWAP over 36 months, with the registered shares representing approximately 879% of current outstanding shares, creating severe dilution risk.
- S-1 registration declared effective on November 12, 2026
- Registration covers 135,135,135 shares for resale by Roth Principal Investments, LLC
- Shares represent approximately 879% of current outstanding shares
- Committed equity facility allows Traws to sell up to $50 million of newly issued shares
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access